Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oral contraceptive and hepatic effects].

G Tarantino1, L Morelli, C Califano

  • 1Istituto di Medicina Interna e Malattie Dismetaboliche, II Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli.

Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques
|June 1, 1990
PubMed
Summary

Synthetic estrogens like DC can cause serious side effects, including cholestasis and liver adenomas. Vascular issues like Budd-Chiari syndrome may occur, but gallbladder disease incidence remains unchanged.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Susceptibility Mapping in Skull Base Chordoma: In Silico Analysis and In Vivo Application Towards Indirect Hypoxia Assessment.

Magnetic resonance in medicine·2025
Same author

Adequate lymphadenectomy and adjuvant capecitabine warrant survival benefit in gallbladder cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients.

ESMO open·2025
Same author

Outcomes of loop ileostomy after rectal resection for cancer: A prospective observational multicenter snapshot study from Multidisciplinary Italian Study group for STOmas (MISSTO).

Techniques in coloproctology·2024
Same author

Corrigendum to "Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications" [Cancer Treat. Rev. 130 (2024) 102816].

Cancer treatment reviews·2024
Same author

[Effect of Plasmafiltration and Adsorption in Cocaine Abuse: A Case Report].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2024

Area of Science:

  • Hepatology
  • Vascular Medicine
  • Endocrinology

Background:

  • Synthetic estrogens are widely used.
  • Estrogen therapy is associated with various potential adverse effects.
  • Understanding these risks is crucial for patient safety.

Purpose of the Study:

  • To summarize the collateral effects of synthetic estrogens, specifically focusing on liver and vascular complications.
  • To investigate the impact of synthetic estrogens on gallbladder disease incidence.

Main Methods:

  • Review of existing literature on synthetic estrogen use and associated adverse events.
  • Analysis of clinical data regarding liver function, adenoma development, and vascular complications.
  • Epidemiological assessment of gallbladder disease rates in relation to estrogen therapy.

Related Experiment Videos

Main Results:

  • Synthetic estrogens can lead to cholestasis, reversible upon discontinuation.
  • Potential for hepatic adenoma development, with a risk of progression to hepatocellular carcinoma.
  • Increased incidence of vascular complications, including hepatic peliosis and Budd-Chiari syndrome.
  • No significant increase in gallbladder disease (cholelithiasis, cholecystitis) observed.

Conclusions:

  • Synthetic estrogens carry significant risks, including hepatotoxicity and vascular events.
  • Close monitoring for liver and vascular complications is essential during synthetic estrogen therapy.
  • Current evidence does not link synthetic estrogen use to increased gallbladder disease.